Marcus (MCS) Releases Quarterly Earnings Results, Beats Estimates By $0.09 EPS

Share on StockTwits

Marcus (NYSE:MCS) issued its quarterly earnings results on Thursday, October 25th. The company reported $0.56 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.47 by $0.09, MarketWatch Earnings reports. The company had revenue of $170.60 million for the quarter, compared to the consensus estimate of $170.47 million. Marcus had a net margin of 11.46% and a return on equity of 12.54%.

Shares of NYSE:MCS traded down $0.22 during midday trading on Friday, reaching $41.28. The company had a trading volume of 126,840 shares, compared to its average volume of 169,081. The company has a market capitalization of $1.16 billion, a P/E ratio of 26.81, a price-to-earnings-growth ratio of 1.47 and a beta of 0.60. Marcus has a 52-week low of $23.55 and a 52-week high of $44.61. The company has a debt-to-equity ratio of 0.59, a quick ratio of 0.49 and a current ratio of 0.47.

The business also recently declared a quarterly dividend, which will be paid on Monday, December 17th. Investors of record on Monday, November 26th will be issued a $0.15 dividend. This represents a $0.60 dividend on an annualized basis and a dividend yield of 1.45%. The ex-dividend date is Friday, November 23rd. Marcus’s dividend payout ratio (DPR) is currently 38.96%.

MCS has been the topic of a number of research analyst reports. B. Riley boosted their price target on shares of Marcus from $36.00 to $40.00 and gave the stock a “$33.70” rating in a report on Monday, July 23rd. Zacks Investment Research downgraded shares of Marcus from a “hold” rating to a “sell” rating in a report on Wednesday, July 25th. Barrington Research reissued a “buy” rating and issued a $36.00 price target on shares of Marcus in a report on Thursday, July 26th. Finally, ValuEngine raised shares of Marcus from a “hold” rating to a “buy” rating in a report on Thursday, July 26th.

In other Marcus news, insider Gregory S. Marcus sold 89,093 shares of the company’s stock in a transaction dated Wednesday, September 12th. The shares were sold at an average price of $41.05, for a total transaction of $3,657,267.65. Following the sale, the insider now directly owns 194,687 shares of the company’s stock, valued at $7,991,901.35. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, Director Bruce J. Olson sold 3,600 shares of the company’s stock in a transaction dated Wednesday, August 15th. The shares were sold at an average price of $36.90, for a total transaction of $132,840.00. Following the sale, the director now directly owns 5,604 shares in the company, valued at $206,787.60. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 171,343 shares of company stock worth $6,988,680. Insiders own 32.88% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: This news story was originally posted by BBNS and is the property of of BBNS. If you are viewing this news story on another publication, it was stolen and republished in violation of United States and international copyright laws. The correct version of this news story can be viewed at https://baseballnewssource.com/2018/11/10/marcus-mcs-posts-quarterly-earnings-results-beats-expectations-by-0-09-eps/2887420.html.

About Marcus

The Marcus Corporation, together with its subsidiaries, owns and operates movie theatres, and hotels and resorts. As of December 28, 2017, the company operated approximately 69 movie theatres with 895 screens in Wisconsin, Illinois, Iowa, Minnesota, Missouri, Nebraska, North Dakota, and Ohio; owned or managed approximately 4,841 hotel and resort rooms; and 19 hotels, resorts, and other properties for third parties in nine states.

Further Reading: Stock Symbols, CUSIP and Other Stock Identifiers

Earnings History for Marcus (NYSE:MCS)

Receive News & Ratings for Marcus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Marcus and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


Leave a Reply

 
© 2006-2018 BBNS.